Treatment and timing in invasive mould disease.

@article{Maertens2011TreatmentAT,
  title={Treatment and timing in invasive mould disease.},
  author={Johan Maertens and Andreas H Groll and Catherine Cordonnier and Rafael de la Camara and Emmanuel Roilides and Oscar Marchetti},
  journal={The Journal of antimicrobial chemotherapy},
  year={2011},
  volume={66 Suppl 1},
  pages={
          i37-43
        }
}
Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed. 

Figures and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

Complications of hematopoietic stem transplantation: Fungal infections.

  • Hematology/oncology and stem cell therapy
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy

  • Turkish journal of haematology : official journal of Turkish Society of Haematology
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009

Recent advances in the management of mucormycosis: from bench to bedside.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009

Voriconazole versus itraconazole for primary prophylaxis of invasive fungal infection in allogeneic hematopoietic cell transplant (HCT) recipients

DI Marks, C Kibbler, A Pagliugi
  • Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy,
  • 2009